Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/26735
Title: | The polarity protein PARD3 and cancer. | Austin Authors: | Atashrazm, Farzaneh;Ellis, Sarah | Affiliation: | Olivia Newton-John Cancer Research Institute Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC, Australia School of Cancer Medicine, La Trobe University, Heidelberg, Victoria, VIC, Australia |
Issue Date: | 2021 | metadata.dc.date: | 2021-06-07 | Publication information: | Oncogene 2021; 40(25): 4245-4262 | Abstract: | Tissue disorganisation is one of the main hallmarks of cancer. Polarity proteins are responsible for the arrangement of cells within epithelial tissues through the asymmetric organisation of cellular components. Partition defective 3 (PARD3) is a master regulator of the Par polarity complex primarily due to its ability to form large complexes via its self-homologous binding domain. In addition to its role in polarity, PARD3 is a scaffolding protein that binds to intracellular signalling molecules, many of which are frequently deregulated in cancer. The role of PARD3 has been implicated in multiple solid cancers as either a tumour suppressor or promoter. This dual functionality is both physiologically and cell context dependent. In this review, we will discuss PARD3's role in tumourigenesis in both laboratory and clinical settings. We will also review several of the mechanisms underpinning PARD3's function including its association with intracellular signalling pathways and its role in the regulation of asymmetric cell division. | URI: | https://ahro.austin.org.au/austinjspui/handle/1/26735 | DOI: | 10.1038/s41388-021-01813-6 | ORCID: | 0000-0003-3471-8160 0000-0002-5772-6051 |
Journal: | Oncogene | PubMed URL: | 34099863 | Type: | Journal Article |
Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.